Clear Filters Pharma’s Big Neuroscience Comeback for treatment of neurodegenerative diseases like Alzheimer’s September 10, 2021 Pharma’s Big Neuroscience Comeback for treatment of neurodegenerative diseases like Alzheimer’s For years, the neuroscience industry has been plagued by a high failure rate of drugs in the clinical stages. Read More Gain Therapeutics, INC. Reports first quarter 2021 financial results August 29, 2021 Gain Therapeutics, INC. Reports first quarter 2021 financial results “We were thrilled to complete our IPO in March on the Nasdaq Global Market Exchange,” stated Sal Calabrese, Chief Financial Officer of Gain. Read More Gain Therapeutics to present at the b. Riley securities’ virtual neuroscience conference August 29, 2021 Gain Therapeutics to present at the b. Riley securities’ virtual neuroscience conference Gain Therapeutics, Inc. is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted Read More Gain Therapeutics announces issuance of two new pct patents covering gba and galc modulator August 29, 2021 Gain Therapeutics announces issuance of two new pct patents covering gba and galc modulator Read More Gain Therapeutics to Present at Jefferies Virtual Healthcare Conference August 29, 2021 Gain Therapeutics to Present at Jefferies Virtual Healthcare Conference Read More Gain Therapeutics to Present at BTIG Virtual Biotechnology Conference August 29, 2021 Gain Therapeutics to Present at BTIG Virtual Biotechnology Conference Read More Gain Therapeutics, INC. Reports second quarter 2021 financial results and business update August 28, 2021 Gain Therapeutics, INC. Reports second quarter 2021 financial results and business update Read More Corporate Presentation August 2024 Corporate Presentation Download
